Dimensional Fund Advisors
CGEM icon

Dimensional Fund Advisors’s Cullinan Oncology CGEM Stock Holding History

Dimensional Fund Advisors’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.1M Buy
1,046,694
+140,666
+16% +$2.09M ﹤0.01% 2059
2026
Q1 		$12.9M Buy
906,028
+57,259
+7% +$736K ﹤0.01% 2165
2025
Q4 		$8.78M Sell
848,769
-335,052
-28% -$3.02M ﹤0.01% 2326
2025
Q3 		$7.02M Sell
1,183,821
-92,717
-7% -$679K ﹤0.01% 2429
2025
Q2 		$9.61M Sell
1,276,538
-26,683
-2% -$214K ﹤0.01% 2289
2025
Q1 		$9.87M Sell
1,303,221
-15,151
-1% -$145K ﹤0.01% 2256
2024
Q4 		$16.1M Buy
1,318,372
+295,467
+29% +$4.25M ﹤0.01% 2087
2024
Q3 		$17.1M Buy
1,022,905
+263,145
+35% +$4.67M ﹤0.01% 2073
2024
Q2 		$13.2M Sell
759,760
-233,617
-24% -$4.97M ﹤0.01% 2138
2024
Q1 		$16.9M Buy
993,377
+77,619
+8% +$1.2M ﹤0.01% 2071
2023
Q4 		$9.33M Buy
915,758
+117,042
+15% +$1.04M ﹤0.01% 2348
2023
Q3 		$7.23M Buy
798,716
+276,049
+53% +$2.87M ﹤0.01% 2400
2023
Q2 		$5.62M Buy
522,667
+176,448
+51% +$1.87M ﹤0.01% 2481
2023
Q1 		$3.54M Buy
+346,219
New +$3.82M ﹤0.01% 2590
2022
Q3 		$145K Buy
+11,284
New +$152K ﹤0.01% 3288

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Dimensional Fund Advisors's CGEM Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Cullinan Oncology (CGEM) stake by 16% in Q2 2026, buying an estimated $2.09M and bringing the position to 1,046,694 shares worth $19.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2059.

Dimensional Fund Advisors first reported a position in CGEM in Q3 2022 and has held it in 15 quarters since. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Dimensional Fund Advisors held 1,046,694 shares of Cullinan Oncology worth $19.1M as of Q2 2026.
  • Dimensional Fund Advisors bought 140,666 Cullinan Oncology shares in Q2 2026, an estimated $2.09M.
  • Cullinan Oncology made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2059 holding.
  • Dimensional Fund Advisors first reported a position in Cullinan Oncology in Q3 2022 and has held it in 15 quarters since.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.